Sherman, K. E., Kang, M., Sterling, R., Umbleja, T., Marks, K., Kiser, J. J., . . . the ACTG 5294 BIRTH Study Team. (2017). Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection. World J Hepatol.
Citação norma ChicagoSherman, Kenneth E., et al. "Phase 3 Trial of First Generation Protease Inhibitor Therapy for Hepatitis C Virus/human Immunodeficiency Virus Coinfection." World J Hepatol 2017.
Citação norma MLASherman, Kenneth E., et al. "Phase 3 Trial of First Generation Protease Inhibitor Therapy for Hepatitis C Virus/human Immunodeficiency Virus Coinfection." World J Hepatol 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.